U.S. authorizes emergency use of an experimental Eli Lilly antibody treatment to fight mild, moderate COVID-19 cases.

WASHINGTON (AP) — U.S. authorizes emergency use of an experimental Eli Lilly antibody treatment to fight mild, moderate COVID-19 cases.

Copyright © 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up